Related Experiment Video
Updated: Aug 14, 2026

Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease
Published on: April 19, 2015
Global mapping of BMAL1 protein-DNA interactions in human retinal Müller cells
Qianyi Luo1, Neel Sangani2, Surabhi Abhyankar1
1Department of Ophthalmology, Indiana University School of Medicine, Eugene and Marilyn Glick Eye Institute, Indianapolis, IN.
Abstract:
The circadian clock, a conserved biologic timekeeping mechanism, is pivotal in orchestrating rhythmic physiologic processes. While extensively studied in the central clock, the involvement of BMAL1 in peripheral clocks, particularly in human Müller cells, remains underexplored. Müller cells, critical for retinal homeostasis, may unveil novel insights into circadian regulation. Employing ChIP-sequencing, we comprehensively mapped BMAL1 binding sites in human Müller cells. The analysis identified 275 reproducible peaks, with predominant distribution across promoters (26.6%), intronic (26.3%), and intergenic (22.1%) regions, with 80% of these confident peaks linked to protein-coding genes. Differential peak analysis revealed 89 unique genes significantly enriched with BMAL1 sites in their promoters, while functional enrichment of the associated genes indicated key biologic processes such as circadian regulation of gene expression, photoperiodism, and glucocorticoid receptor signaling pathway regulation. Motif analysis revealed a highly conserved 6-nucleotide motif, CACGTG, appearing in 89.09% of the peaks. Analysis of the binding sites across genomic regions highlighted the robust BMAL1 binding, further confirmed by qPCR validation of circadian targets such as G6PC3, CIART, PER1, and TXNIP, which are critical for Müller cell health, along with SHMT2 and MALAT1, which have emerged as novel genes that may have implications for Müller cell health. Our findings unveil the regulatory landscape of BMAL1 in Müller cells, contributing to a broader understanding of the clock-mediated mechanism in ocular tissues. These insights hold therapeutic potential for circadian-related retinal diseases, presenting avenues for chronotherapeutic interventions.
Insights
Researchers mapped BMAL1 binding sites in human Müller cells, revealing key genes involved in circadian regulation and retinal health. This work offers potential for treating circadian-related eye diseases.
Area of Science:
- Ophthalmology
- Chronobiology
- Molecular Biology
Background:
- The circadian clock regulates physiological processes, but its role in peripheral clocks, especially in human Müller cells, is not well understood.
- Müller cells are crucial for retinal homeostasis and may offer insights into circadian regulation within the eye.
Purpose of the Study:
- To comprehensively map BMAL1 binding sites in human Müller cells.
- To identify genes and biological processes regulated by BMAL1 in these cells.
- To explore the therapeutic potential for circadian-related retinal diseases.
Main Methods:
- Chromatin immunoprecipitation sequencing (ChIP-sequencing) was used to identify BMAL1 binding sites.
- Bioinformatic analysis was performed to analyze peak distribution, gene enrichment, and motif discovery.
- Quantitative PCR (qPCR) was employed to validate circadian target genes.
Main Results:
- 275 reproducible BMAL1 binding sites were identified, predominantly in promoters, introns, and intergenic regions.
- 89 unique genes were significantly enriched with BMAL1 promoter binding, involved in circadian regulation and photoperiodism.
- A conserved CACGTG motif was found in 89.09% of peaks, and qPCR validated known and novel targets like G6PC3, CIART, PER1, TXNIP, SHMT2, and MALAT1.
Conclusions:
- This study elucidates the BMAL1 regulatory landscape in human Müller cells, expanding the understanding of clock mechanisms in ocular tissues.
- The identified BMAL1 targets are critical for Müller cell health and suggest potential therapeutic strategies for circadian-related retinal disorders.
- These findings open avenues for chronotherapeutic interventions in ophthalmology.

